- AU$56.10m
- AU$53.29m
- AU$42.06m
- 58
- 62
- 39
- 55
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.12 | ||
| Price to Tang. Book | 3.22 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.27 | ||
| EV to EBITDA | 17.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.1% | ||
| Return on Equity | 8.16% | ||
| Operating Margin | 2.67% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 31.79 | 33.04 | 33.18 | 35.85 | 42.05 | n/a | n/a | 7.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -45.69 | +245.13 | +26.36 | -49.59 | +27.09 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Austco Healthcare Limited is an international provider of healthcare communication and clinical workflow management solutions. The principal activities of the business are the manufacture, service, supply, and distribution of healthcare communications equipment and software. It offers two nurse call systems: Tacera and Medicom. Tacera is an Internet protocol (IP)-based nurse call and clinical communications platform that offers flexibility to support processes and the way caregivers work. Tacera offers various options for patients and nurses, such as pendants, pillow speakers, call points, pull cords, annunciators, lights, touchscreen stations and audio devices. Medicom is a nurse call solution and features a comprehensive range of call types, priority levels, alarm handling and call indication options. It is also focused on enhancing its real-time-locating (RTLS) solution and software suite with advanced clinical workflow, task management, and business intelligence solutions.
Directors
- Graeme Billings NEC
- Clayton Astles CEO
- Brendan Maher CFO
- Victor Almeida GMG
- Peter DiBari GMG
- Peter Kamarinos OTH
- Brett Burns NID
- Anthony Glenning NID
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 2nd, 2004
- Public Since
- September 24th, 2004
- No. of Shareholders
- 991
- No. of Employees
- 174
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 295,256,748
- Address
- Unit 1/31 Sabre Dr, Port Melbourne, MELBOURNE, 3207
- Web
- https://austcohealthcare.com/
- Phone
- +61 392099688
- Auditors
- Grant Thornton Audit Pty Ltd
Upcoming Events for AHC
Similar to AHC
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Austco Healthcare share price?
As of Today at 19:03 UTC, shares in Austco Healthcare are trading at AU$0.19. This share price information is delayed by 15 minutes.
How has the Austco Healthcare share price performed this year?
Shares in Austco Healthcare last closed at AU$0.19 and the price had moved by +46.15% over the past 365 days. In terms of relative price strength the Austco Healthcare share price has outperformed the ASX All Ordinaries Index by +36.14% over the past year.
What are the analyst and broker recommendations for Austco Healthcare?
There is no consensus recommendation for this security.
What is the Austco Healthcare dividend yield?
Austco Healthcare does not currently pay a dividend.
Does Austco Healthcare pay a dividend?
Austco Healthcare does not currently pay a dividend.
When does Austco Healthcare next pay dividends?
Austco Healthcare does not currently pay a dividend.
How do I buy Austco Healthcare shares?
To buy shares in Austco Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Austco Healthcare?
As of the previous close price of AU$0.19, shares in Austco Healthcare had a market capitalisation of AU$56.10m.
Where are Austco Healthcare shares listed?
Here are the trading details for Austco Healthcare:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AHC
What kind of share is Austco Healthcare?
Based on an overall assessment of its quality, value and momentum Austco Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Austco Healthcare share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Austco Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Austco Healthcare. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -10.65%.
As of the last closing price of AU$0.19, shares in Austco Healthcare were trading +6.69% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Austco Healthcare PE Ratio?
The Austco Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.19.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Austco Healthcare?
Austco Healthcare's management team is headed by:
- Graeme Billings - NEC
- Clayton Astles - CEO
- Brendan Maher - CFO
- Victor Almeida - GMG
- Peter DiBari - GMG
- Peter Kamarinos - OTH
- Brett Burns - NID
- Anthony Glenning - NID